chevron_leftBack
As of 7 June 2026, Otofarma S.p.A. has a market cap of $27.01M USD, ranking #34978 globally and #281 in Italy.
It ranks #3155 in the Healthcare sector, and #673 in the Medical Devices industry.
Key Stats
Market Cap
$27.01MUSD
23.26M EUR
Forward PE
21.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Giovanna Bartolomucci
open_in_new
Employees
115
Founded
2016
Website
otofarmaspa.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | -8.2% | -10% | -18% | -27% | -38% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
OTO
ISIN: IT0005663361
Shares Out.:
Shares Outstanding:
5.947M1
Shares Float:
639.302K2
|
4.04 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Otofarma S.p.A.
Otofarma S.P.A. engages in production and distribution of custom-made hearing aids. The company provides hearing aid solutions, including custom-made, in-the-canal, and behind-the-ear hearing aids, rechargeable hearing aids, and distributes complementary accessories. The company was incorporated in 2016 and is based in Napoli, Italy with an additional office in Milan, Italy. As of August 5, 2025, Otofarma S.P.A. operates as a subsidiary of Bartolomucci Holding s.r.l.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: STVN
|
$4.44B
16K%
|
27.2
|
|
MIL: DIA
|
$3.57B
13K%
3.07B EUR
|
20.3
|
|
MIL: ELN
|
$1.21B
4K%
1.05B EUR
|
21.4
|
|
MIL: SFL
|
$804.96M
3K%
693.03M EUR
|
14.4
|
|
MIL: SVS
|
$55.92M
107%
48.14M EUR
|
7.1
|
|
|
$28.57M
5.8%
24.6M EUR
|
17.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
641K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
595K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
589K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
468K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
447K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
377K%
|
22.2
|
chevron_leftBack